Singapore’s M&L Healthcare Investments has announced the sale of its arterial ischemia treatment technology startup LimFlow, while Japanese mobile operator NTT Docomo has joined a consortium led by Mitsui & Co. to bid for a majority stake in Malaysia’s Edotco Group.
Edited by: Pramod Mathew
